annual D&A:
$19.26M-$578.00K(-2.91%)Summary
- As of today (June 29, 2025), CRSP annual depreciation & amortization is $19.26 million, with the most recent change of -$578.00 thousand (-2.91%) on December 31, 2024.
- During the last 3 years, CRSP annual D&A has risen by +$1.31 million (+7.27%).
- CRSP annual D&A is now -20.33% below its all-time high of $24.17 million, reached on December 31, 2022.
Performance
CRSP Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$4.74M-$106.00K(-2.19%)Summary
- As of today (June 29, 2025), CRSP quarterly depreciation & amortization is $4.74 million, with the most recent change of -$106.00 thousand (-2.19%) on March 31, 2025.
- Over the past year, CRSP quarterly D&A has dropped by -$97.00 thousand (-2.01%).
- CRSP quarterly D&A is now -34.85% below its all-time high of $7.27 million, reached on June 30, 2022.
Performance
CRSP quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$19.16M-$97.00K(-0.50%)Summary
- As of today (June 29, 2025), CRSP TTM depreciation & amortization is $19.16 million, with the most recent change of -$97.00 thousand (-0.50%) on March 31, 2025.
- Over the past year, CRSP TTM D&A has dropped by -$457.00 thousand (-2.33%).
- CRSP TTM D&A is now -23.02% below its all-time high of $24.89 million, reached on June 30, 2022.
Performance
CRSP TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CRSP Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.9% | -2.0% | -2.3% |
| 3 y3 years | +7.3% | -21.6% | -9.9% |
| 5 y5 years | +307.6% | +126.5% | +219.2% |
CRSP Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -20.3% | +7.3% | -34.9% | at low | -23.0% | at low |
| 5 y | 5-year | -20.3% | +307.6% | -34.9% | +126.5% | -23.0% | +219.2% |
| alltime | all time | -20.3% | >+9999.0% | -34.9% | +4367.9% | -23.0% | >+9999.0% |
CRSP Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $4.74M(-2.2%) | $19.16M(-0.5%) |
| Dec 2024 | $19.26M(-2.9%) | $4.84M(+2.2%) | $19.26M(-0.3%) |
| Sep 2024 | - | $4.74M(-2.2%) | $19.32M(-1.0%) |
| Jun 2024 | - | $4.84M(+0.2%) | $19.50M(-0.6%) |
| Mar 2024 | - | $4.83M(-1.4%) | $19.62M(-1.1%) |
| Dec 2023 | $19.84M(-17.9%) | $4.90M(-0.5%) | $19.84M(-4.6%) |
| Sep 2023 | - | $4.92M(-0.7%) | $20.78M(-0.4%) |
| Jun 2023 | - | $4.96M(-1.8%) | $20.88M(-10.0%) |
| Mar 2023 | - | $5.05M(-13.6%) | $23.18M(-4.1%) |
| Dec 2022 | $24.17M(+34.6%) | $5.85M(+16.5%) | $24.17M(-1.7%) |
| Sep 2022 | - | $5.02M(-31.0%) | $24.59M(-1.2%) |
| Jun 2022 | - | $7.27M(+20.4%) | $24.89M(+17.0%) |
| Mar 2022 | - | $6.04M(-3.5%) | $21.28M(+18.5%) |
| Dec 2021 | $17.95M(+95.5%) | $6.26M(+17.6%) | $17.95M(+25.9%) |
| Sep 2021 | - | $5.32M(+45.7%) | $14.26M(+26.5%) |
| Jun 2021 | - | $3.65M(+34.5%) | $11.27M(+14.9%) |
| Mar 2021 | - | $2.71M(+5.8%) | $9.81M(+6.8%) |
| Dec 2020 | $9.18M | $2.57M(+9.9%) | $9.18M(+14.1%) |
| Sep 2020 | - | $2.33M(+6.5%) | $8.05M(+15.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $2.19M(+4.8%) | $7.00M(+16.6%) |
| Mar 2020 | - | $2.09M(+46.0%) | $6.00M(+27.1%) |
| Dec 2019 | $4.72M(+34.3%) | $1.43M(+11.6%) | $4.72M(+11.5%) |
| Sep 2019 | - | $1.28M(+7.1%) | $4.24M(+10.4%) |
| Jun 2019 | - | $1.20M(+47.5%) | $3.84M(+9.5%) |
| Mar 2019 | - | $812.00K(-14.1%) | $3.50M(-0.4%) |
| Dec 2018 | $3.52M(+16.4%) | $945.00K(+7.0%) | $3.52M(+4.1%) |
| Sep 2018 | - | $883.00K(+2.1%) | $3.38M(+2.8%) |
| Jun 2018 | - | $865.00K(+4.7%) | $3.29M(+5.1%) |
| Mar 2018 | - | $826.00K(+2.5%) | $3.13M(+3.5%) |
| Dec 2017 | $3.02M(+226.9%) | $806.00K(+1.8%) | $3.02M(+15.0%) |
| Sep 2017 | - | $792.00K(+12.2%) | $2.63M(+26.8%) |
| Jun 2017 | - | $706.00K(-1.9%) | $2.07M(+34.8%) |
| Mar 2017 | - | $720.00K(+74.8%) | $1.54M(+66.4%) |
| Dec 2016 | $925.00K(+628.3%) | $412.00K(+74.6%) | $925.00K(+80.3%) |
| Sep 2016 | - | $236.00K(+38.0%) | $513.00K(+85.2%) |
| Jun 2016 | - | $171.00K(+61.3%) | $277.00K(+161.3%) |
| Mar 2016 | - | $106.00K | $106.00K |
| Dec 2015 | $127.00K(+234.2%) | - | - |
| Dec 2014 | $38.00K | - | - |
FAQ
- What is CRISPR Therapeutics AG annual depreciation & amortization?
- What is the all time high annual D&A for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual D&A year-on-year change?
- What is CRISPR Therapeutics AG quarterly depreciation & amortization?
- What is the all time high quarterly D&A for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly D&A year-on-year change?
- What is CRISPR Therapeutics AG TTM depreciation & amortization?
- What is the all time high TTM D&A for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG TTM D&A year-on-year change?
What is CRISPR Therapeutics AG annual depreciation & amortization?
The current annual D&A of CRSP is $19.26M
What is the all time high annual D&A for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual depreciation & amortization is $24.17M
What is CRISPR Therapeutics AG annual D&A year-on-year change?
Over the past year, CRSP annual depreciation & amortization has changed by -$578.00K (-2.91%)
What is CRISPR Therapeutics AG quarterly depreciation & amortization?
The current quarterly D&A of CRSP is $4.74M
What is the all time high quarterly D&A for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly depreciation & amortization is $7.27M
What is CRISPR Therapeutics AG quarterly D&A year-on-year change?
Over the past year, CRSP quarterly depreciation & amortization has changed by -$97.00K (-2.01%)
What is CRISPR Therapeutics AG TTM depreciation & amortization?
The current TTM D&A of CRSP is $19.16M
What is the all time high TTM D&A for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM depreciation & amortization is $24.89M
What is CRISPR Therapeutics AG TTM D&A year-on-year change?
Over the past year, CRSP TTM depreciation & amortization has changed by -$457.00K (-2.33%)